Institutional investors hold a majority ownership of AMGN through the 82.33% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB ... Bought 1.5 Million shares of Amgen
NNIP ADVISORS BV Bought 235.6 Thousand shares of Amgen
BNP PARIBAS ARBITRAGE SNC Bought 221.1 Thousand shares of Amgen